EcoDrugPlus

Phosphodiesterase 10a

Ensembl ID : ENSCAFG00020019197
Gene Symbol: PDE10A
3 Cross references
207 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSCAFG00020007608
Gene Symbol: PDE3A
3 Cross references
258 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSCAFG00020017213
Gene Symbol: PDE3B
3 Cross references
203 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSCAFG00020024472
Gene Symbol: PDE4A
3 Cross references
250 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSCAFG00020020440
Gene Symbol: PDE4B
3 Cross references
298 Possible Orthologues:

Phosphodiesterase 4c

Ensembl ID : ENSCAFG00020012094
Gene Symbol: PDE4C
1 Cross references
70 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSCAFG00020023895
Gene Symbol: PDE4D
3 Cross references
130 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSCAFG00020017554
Gene Symbol: PDE5A
3 Cross references
208 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSCAFG00020016027
Gene Symbol: PDE7A
3 Cross references
240 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSCAFG00020022549
Gene Symbol: PDE7B
3 Cross references
174 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSCAFG00020018526
Gene Symbol: PDE9A
3 Cross references
193 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSCAFG00020019414
Gene Symbol: PIK3R1
3 Cross references
259 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).